title: Neutrophil dysfunction in a family with a SAPHO syndrome-like phenotype.
abstract: SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis, osteitis) is an inflammatory disorder of the bone, skin, and joints. We describe a family with multiple affected members who segregate a SAPHO syndrome-like phenotype, and we report the results of neutrophil studies and candidate gene analysis. We obtained written informed consent and a family history and reviewed medical records. We collected DNA and sequenced candidate genes, and we performed functional studies on neutrophils isolated from the proband and her mother. The pedigree segregated chronic osteomyelitis and cutaneous inflammation in a pattern that suggested an autosomal-dominant disorder. No coding sequence mutations were detected in PSTPIP1, PSTPIP2, LPIN2, SH3BP2, or NCF4. Analysis of neutrophil function in the proband, including nitroblue tetrazolium tests, myeloperoxidase assays, neutrophil chemotaxis, and neutrophil chemotaxis assays, revealed no identifiable abnormalities. However, an abnormality in the luminol, but not the isoluminol, respiratory burst assays following stimulation with phorbol myristate acetate (PMA) was detected in neutrophils isolated from the affected proband. Internal oxidant production was also reduced in the proband and her mother when neutrophils were treated with fMLP with or without platelet-activating factor, PMA alone, or tumor necrosis factor alpha alone. This family segregates a disorder characterized by chronic inflammation of the skin and bone. Functional differences in neutrophils exist between affected individuals and controls. The biologic significance of this defect remains unknown. Identification of the gene defect will help identify an immunologic pathway that, when dysregulated, causes inflammation of the skin and bone.
authors.affiliation: Department of Medical Microbiology and Immunology and Pediatrics, University of Wisconsin, Madison, WI 53706, USA.
authors.forename: Polly J
authors.initials: PJ
authors.lastname: Ferguson
authors.forename: Mary A
authors.initials: MA
authors.lastname: Lokuta
authors.forename: Hatem I
authors.initials: HI
authors.lastname: El-Shanti
authors.forename: Leah
authors.initials: L
authors.lastname: Muhle
authors.forename: Xinyu
authors.initials: X
authors.lastname: Bing
authors.forename: Anna
authors.initials: A
authors.lastname: Huttenlocher
mesh_terms: D020083:Acquired Hyperostosis Syndrome / Q000188:drug therapy / Q000235:genetics*; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D018375:Neutrophil Activation / Q000235:genetics*; D010375:Pedigree; D017382:Reactive Oxygen Species / Q000378:metabolism; D016897:Respiratory Burst / Q000235:genetics*
chemical_list: D000305:Adrenal Cortex Hormones; D017382:Reactive Oxygen Species